Jafron Biomedical

Established in 1989, Jafron engaged in research, production and marketing of biomaterials and medical devices. Jafron products focus on removal of toxins in blood for different diseases, covering critical care, nephrology, hepatology, and immunological diseases, etc. With nearly 20-years clinical experience, Jafron hemoperfusion treatments have been adopted in over 4500 hospitals in 50 countries, with about 3 million cases of clinical application annually. Listed on ChiNext in 2016, Jafron is a now leading enterprise in Chinese blood purification industry. In 2020, as a comprehensive adsorption solution provider，Jafron will keep exploring other novel medical fields to realize the vision of "Health Technology for a Better World".